# China NMPA Inspection - Guangzhou Ouruisi Biotechnology Co., Ltd - January 17, 2020

Source: https://www.globalkeysolutions.net/records/china_inspection/guangzhou-ouruisi-biotechnology-co-ltd/043cd2e9-2dc4-409b-a149-857920649bcb/
Source feed: China

> China NMPA unannounced inspection for Guangzhou Ouruisi Biotechnology Co., Ltd published January 17, 2020. The National Medical Products Administration (NMPA) of China issued a public notification on January 17, 2020, announcing an unannounced inspection co

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notification of Unannounced Inspection of Guangzhou Ruixin Biotechnology Co., Ltd.
- Company Name: Guangzhou Ouruisi Biotechnology Co., Ltd
- Publication Date: 2020-01-17
- Product Type: cosmetics
- Summary: The National Medical Products Administration (NMPA) of China issued a public notification on January 17, 2020, announcing an unannounced inspection concerning Guangzhou Ruixin Biotechnology Co., Ltd. This document serves as an official communication from the NMPA, highlighting the regulatory body's proactive oversight in ensuring compliance within the medical and cosmetic product industries. Unannounced inspections are a critical tool employed by regulatory authorities worldwide, including the NMPA, to assess manufacturers' adherence to stringent quality, safety, and operational standards without prior warning. Such inspections aim to provide an unbiased snapshot of a company's real-time operational practices and compliance status with relevant Chinese regulations governing product development, manufacturing, and distribution. While the notification identifies the inspected entity as Guangzhou Ruixin Biotechnology Co., Ltd., and establishes the regulatory authority involved, it functions solely as an announcement. The provided text does not elaborate on the specific dates of the inspection, the nature or main findings of any potential violations or issues uncovered during the review, the detailed regulatory framework applied, or any subsequent required corrective actions or enforcement measures. Therefore, a comprehensive overview of the inspection's outcomes, specific non-compliances, or mandated remedies cannot be derived from this notification alone, as it solely indicates the occurrence of a regulatory action.

Company: https://www.globalkeysolutions.net/companies/guangzhou-ouruisi-biotechnology-co-ltd/92ee030e-58f6-4d19-ba8d-7fe10793c034/